What is HFA Career Café ?
HFA Career Café is the meeting place for the future generation of cardiologists.
In a focused 20-minute one-on-one interview, selected participants have the invaluable opportunity to connect with leaders in their field, gaining tailored career advice and guidance.
This unique initiative offers a rare opportunity to build meaningful connections that can lead to lasting professional relationships.
Important dates
HFA Career Café 2025 will take place in the HFA Members Lounge on:
- Sunday, 18 May at 17:15
- Monday, 19 May at 17:15
Each session will be followed by a short networking cocktail to continue the discussion.
Registration will open on 14 March 2025.
Am I eligible?
In order to participate, you must fulfil the mandatory eligibility criteria:
- Under 40 years old or in training
- Registered for Heart Failure 2025: Register now
- HFA Silver, Gold or Fellow Member: Become an HFA Member now
IMPORTANT: Applicants must not simultaneously hold any conflicting roles.
The registration will open on the 14 March.
Schedule of the mentors
Sunday, 18 May (17:15–18:15)
- Antonio Bayes Genis
- Biykem Bozkurt
- Javed Butler
- Maria Generosa Crespo-Leiro
- Dana Dawson
- Camilla Hage
- Friedrich Koehler
- Lars Lund
- Davor Milicic
- Mark C Petrie
- Ivan Stankovic
- Carsten Tschoepe
- Peter Van Der Meer
- Linda Van Laake
- Adriaan Voors
Monday, 19 May (17:15–18:15)
- Maja Cikes
- Kevin Damman
- Victoria Delgado
- Justin Ezekowitz
- Pardeep Jhund
- Chris Kapelios
- Alexandre Mebazaa
- Wilfried Mullens
- Amina Rakisheva
- Frank Ruschitzka
- Gianluigi Savarese
- Petar Seferovic
- Muthiah Vaduganathan
- Frederik Hendrik Verbrugge
Get to know your Mentors
Antonio Bayes Genis
Dr Antoni Bayes-Genis is Head of the Heart Institute at Hospital Universitari Germans Trias i Pujol in Badalona (Barcelona, Spain), director of the ICREC (Heart Failure and Cardiac Regeneration) Research Program. Dr. Bayes-Genis is HFA Executive board member and HFA Clinical Section Chair. He is a Full Professor and past vice-Dean at Autonomous University of Barcelona. His research is focused in two main areas, one more clinical and another basic-translational. From the clinical standpoint he is interested in precision medicine in heart failure, biomarkers, sudden death, devices, new treatment options and epidemiology. At the basic-translational level he is focused on novel regenerative approaches to rejuvenate the heart, including tissue engineering, cell-derived products and other things. He has published over 620 articles with more than 20000 citations. He is the inventor of 9 international patents.
Place of work
University Hospital Germans Trias and Pujol de Badalona - Badalona, Spain
Alexandre Mebazaa
Alexandre Mebazaa is Professor of Medicine at Université Paris Cité (France), Chair of Department of Anesthesia & Critical Care and expert in trials in critical conditions. He leads a large research group on biomarkers and biotherapies in critical conditions, named MASCOT granted by the Université de Paris Cité and Inserm. He is part of the task force that wrote the 2021 ESC/HFA Guidelines of Heart Failure and the 2023 addendum. He was PI and co-PI of several trials including STRONG-HF published in Lancet in 2022.
Place of work
Hospital Lariboisiere, Paris (France)
Amina Rakisheva
Dr Amina Rakisheva is a Heart Failure specialist, Consultant in Cardiology Department, Scientific Research Institute of Cardiology and Internal Medicine, Almaty, Kazakhstan. She is elected Board Member of the Heart Failure Association of the ESC, ESC Young Community Board Member in 2020 and she was elected Member of the ESC Clinical Practice Guidelines of the ESC. Since 2018 to the present time, she has been elected as a Secretary of the Association of Cardiologists of Kazakhstan and coordinates National Heart Failure Guidelines. Amina is also Member of the Editorial Board JACC: Case Reports and joined CFR Editorial Board in 2021. Her research interests include heart failure disease management particular heart failure with preserved ejection fraction and comorbidity
Place of work
City Cardiology Center, Almaty (Kazakhstan)
Adriaan Voors
Adriaan Voors Professor of Cardiology and specializes in heart failure. Since July 2003, Professor Voors works as a Cardiologist in the University Medical Centre Groningen, The Netherlands. In 2007, he became Established Clinical Investigator of the Netherlands Heart Foundation, and in May 2010, he became Professor of Cardiology at the University Medical Center Groningen.
Prof. Voors is supervising a research group of students, MD-PhD-fellows and post-docs mainly on using-omics data to increase our knowledge on pathophysiology leading to personalized therapies in heart failure. He is an editorial board member of several heart failure journals. He is/was involved as principal investigator/executive/steering committee member of 58 clinical trials on novel therapies in acute and chronic heart failure. Prof. Voors was the co-chair of the 2016 ESC Heart Failure Guidelines. He has (co-) authored more than 800 peer-reviewed papers and several books and chapters, his Hirsch-index is 119.
Place of work
University Medical Centre Groningen, Groningen (Netherlands (The))
Biykem Bozkurt
Dr. Bozkurt is The Mary and Gordon Cain Chair in Cardiology and Professor of Medicine, Senior Dean of Faculty at Baylor College of Medicine, W.A. “Tex” and Deborah Moncrief, Jr., Chair in Medicine in Houston Texas USA. She is an advanced heart failure and cardiac transplantation cardiologist, Medicine Department Chair at the DeBakey VA Medical Center, Director of the Winters Center for Heart Failure and Associate Director of Cardiovascular Research Institute at Baylor College of Medicine. Dr. Biykem Bozkurt is a Past President for Heart Failure Society of America. She is the Editor in Chief of JACC: Heart Failure, Immediate Past Chair of the AHA/ACC Task Force for Performance Metrics, Vice Chair of the AHA/ACC Heart Failure Guidelines Writing Group, past Chair of the AHA/ACCF Task Force for Data Standards.
Place of work
Baylor College of Medicine, Houston (United States of America)
Camilla Hage
I have a clinical and research interest for heart failure with more than 25 years of experience within cardiovascular and heart failure research. I initiate, design, lead and coordinate national and international clinical trials. My research profile is focused on elucidating pathophysiological mechanisms in heart failure and evaluating potential novel treatments. Primarily my interest lies in phenotyping of HFpEF by deep characterization models using imaging, proteomics, metabolomics, transcriptomics and genomics added by traditional epidemiological analysesssor Dawson is also chair of the ESC Working Group on Myocardial Function for the 2022-2024 mandate.
Place of work
Karolinska University Hospital, Stockholm (Sweden)
Chris Kapelios
Chris J. Kapelios received his MD summa cum laude from the National and Kapodistrian University of Athens in 2010. He went on to complete his Ph.D. on myocardial ischemia-reperfusion injury in 2016. He received his MSc in Health Economics, Outcomes and Management in Cardiovascular Sciences with Distinction from the London School of Economics in 2019. He is board certified in Cardiology since 2021. Previously a Heart Failure fellow at the Royal Brompton Hospital, London, UK, and an Advanced Heart Failure and Transplant fellow at the University of Utah, Salt Lake City, USA, he currently works as an attending Heart Failure and Transplantation cardiologist at the Onassis Cardiac Surgery Center, Athens, Greece. His research interest focuses primarily on advanced heart failure, hemodynamics, decongestion and pharmacotherapy, topics on which he has published to date more than 85 articles in peer-reviewed journals.
Place of work
Onassis Cardiac Surgery Center, Athens (Greece)
Carsten Tschoepe
Univ.-Prof. Dr. med. Carsten Tschöpe Head of Advanced Theranotics in Cardiomyopathies (ATiC) Berlin Institute of Health at Charite (BIH)- Universitätsmedizin Berlin BIH Center for Regenerative Therapies (BCRT) Department of Cardiology, Campus Virchow Charité University Medicine, corporate member of Freie Universtät und Humboldt-Universität zu Berlin Augustenburgerplatz 1 13353 Berlin, Germany
Place of work
German Heart Centre Berlin, Berlin (Germany)
Dana Dawson
Professor Dawson graduated in Medicine at the University of Iasi, Romania. After completing her MRCP with the Royal College of Physicians in London she read for a D. Phil in Cardiovascular Medicine at Merton College, University of Oxford. She trained in Cardiology in Edinburgh and London in the UK and at the University of Virginia in Charlottesville, USA. She is a Professor of Cardiovascular Medicine and Consultant Cardiologist at the University of Aberdeen and Aberdeen Royal Infirmary. Her research interests are varied, from acute stress induced (Takotsubo) cardiomyopathy to exercise based interventions to further mechanistic knowledge of cardio-metabolic health in diabetes and cardiomyopathies. She is exploring specific interventions in randomised controlled studies of heart failure, mechanistic substrate of beta-blocker benefit in COPD patients and anthracycline-induced myocardial insult in patients with breast cancer, as well as the novel Fast Field-cycling cardiac MRI. Professor Dawson is also chair of the ESC Working Group on Myocardial Function for the 2022-2024 mandate.
Place of work
University of Aberdeen, Aberdeen (United Kingdom of Great Britain & Northern Ireland)
Davor Milicic
Davor Milicic is a full professor of Internal medicine and Cardiology at the University of Zagreb School of Medicine since 2009. He was a dean of the foremementioned School of Medicine in two mandates, from 2009-2015. His area of expertise is heart failure, advanced heart failure, heart transplantation. mechanical circulatory support and intensive and acute cardiology. At the University Hospital Centre Zagreb, he serves as a Director of the Heart Transplantation Programme since 2005, and since 2009. he is a Chairman of the Department of Cardiovascular Diseases. Since 2003. he is a president of the Croatian Cardiac Society. In 2012. he became founding director of the Croatian Heart House-the National Heart Foundation, which as a member of the European Heart Network. He was the ESC Board member (Councior) 2013-2015, and HFA-ESC Board Member 2016-. He was elected as a full member of the Croatian Academy of Sciences and Arts in 2012 and elected as a Vice President 2019-2023..
Place of work
University Hospital Centre Zagreb, Zagreb (Croatia)
Faiez Zannad
MD, PhD, Cardiologist, Clinical pharmacologist. Trained at Université de Lorraine, Université of Lyon, France and Medical Research Council (Oxford, UK). Currently, Emeritus Professor of Therapeutics at Université de Lorraine, France. As a trialist, he contributed to building the evidence supporting modern HF therapy, notably with beta-blockers, RAASi and MRAs. As a clinical scientist his work focuses on fibrosis and biomarkers. He has served as Chairman of the French Society of Hypertension, of the ESC Working Group on Pharmacology and Drug Therapy. He is the founder of the Global CardioVascular Clinical Trialists (CVCT) Forum and Workshop with meetings in Paris, Washington DC, in Asia and the Middle East. Professor Zannad published more than 750 peer-reviewed papers. He received the 2014 European Society of Hypertension Paul Milliez Award and the 2017 Lifetime Achievement Award from the ESC-HFA and served as an Eugene Braunwald Scholar in 2019 at Harvard Medical School.
Place of work
University of Lorraine, Vandoeuvre-Les-Nancy (France)
Folkert Asselbergs
Prof. Dr. Folkert W. Asselbergs is a consultant cardiologist, Prof of Precision medicine at the Institute of Cardiovascular Science and Institute of Health Informatics, University College London, Director BRC Clinical and Research Informatics Unit, UCLH, chair data infrastructure Dutch Cardiovascular Alliance (www.dcvalliance.nl), and associate editor of the European Heart Journal for the section digital innovation. He recently founded the nudging unit that will provide a framework to conduct pragmatic trials embedded within routine care for knowledge discovery and improvement of patient care by increasing guideline adherence (www.nudgingtrials.com).He published over 650 peer-reviewed papers and is editor of the textbook "Clinical Applications of Artificial Intelligence in Real-World Data". Prof Asselbergs is coordinator and co-PI in several(inter-) national consortia in the field of trustworthy AI, translation data science and digital health (www.ai4hf.com, heart4data.nl, www.mydigitwin.nl, www.datatools4heart.eu).
Place of work
Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
Friedrich Koehler
Friedrich Koehler, MD, FESC is Senior Physician in Cardiology at the Medical Department, Division of Cardiology and Angiology, Charité - Universitätsmedizin Berlin and Professor for Cardiovascular Telemedicine. He is Director of the Centre for Cardiovascular Telemedicine which is the specialized in research and development projects of remote patient management of heart failure patients. From 2013-2018 he was Principial Investigator of the public funded randomized controlled trial „Telemedical Interventional Management in Heart Failure II“(TIM-HF2, NCT01878630) with 1,538 heart failure patients. Also, he is working in task forces for Digital Medicine in the European Society of Cardiology and German Society for Internal Medicine (DGIM). Since 2019 he is consortium leader of the R&D project „TELEMED5000“, funded by the German Federal Ministry of Economic Affairs and Energy, focussing on artifical intelligence in remote patient management of cardiovascular patients.
Place of work
Charite University Hospital, Berlin (Germany)
Franck Ruschitzka
Professor Frank Ruschitzka, MD, FRCP (Edinburgh), FESC is Chairman of the University Heart Center and the Department of Cardiology at the University Hospital in Zürich, Switzerland. Professor Ruschitzka received his medical degree in 1989 and has specialized in internal medicine and cardiology at the Universities of Göttingen and Zürich. Professor Ruschitzka received numerous awards, including the Cardiovascular Science Award of the Swiss Society of Cardiology, the annual Götz-Preis of the Medical Faculty of the University of Zürich for excellence in clinical medicine and research as well as the Honoris Causa Doctorate of the University of Medicine “Carol Davila” Bucharest. Professor Ruschitzka is Past-President of the Heart Failure Association of the ESC. Professor Ruschitzka`s research focuses on the development of novel drugs, devices and interventions, in heart failure in particular. He is one of the Highly Cited Researchers in the field of Clinical Medicine 2022 (Web of Science)
Place of work
University Heart Center, Zurich, Switzerland
Frederik Hendrik Verbrugge
Frederik H. Verbrugge is a Cardiologist/Intensive Care physician with dedicated interest in heart failure, (exercise) hemodynamics & cardiorenal physiology. Prof. Dr. Verbrugge graduated as M.D. in 2010 (KU Leuven, Belgium), obtained his Ph.D. in 2015 (Hasselt University, Belgium) & received an M.Sc. in Clinical Trials in 2022 (Oxford University, UK). He is currently employed as Clinic Head/Clinical Professor at University Hospital Brussels/Vrije Universiteit Brussel (Belgium), where he cares for patients with heart failure & cardiac devices, attends the cardiac intensive care unit, and runs the exercise physiology lab. Prof. Dr. Verbrugge currently is board member of the Acute Cardiovascular Care Assocation of the European Society of Cardiology and serves as Deputy Editor for European Heart Journal: Acute Cardiovascular Care as well as Editorial Consultant for JACC: Heart Failure.
Place of work
University Hospital (UZ) Brussels, Brussels (Belgium)
Gianluigi Savarese
Gianluigi Savarese is currently Associate Professor of Cardiology and Senior Lecture at Karolinska Institutet, Stockholm (Sweden) where he is the Head of the Heart Failure and Arrhythmia Research. He is also Senior Cardiologist Consultant at the Southern Hospital in Stockholm. Over the last few years, he has published >350 articles on top peer-reviewed journals. Major focus of his research is on heart failure, with a particular interest in implementing use of guidelines recommended treatments, and phenotyping heart failure for improving clinical trial design. He is heavily involved in registry studies (Swedish Heart Failure Registry, ESC registries) and clinical trials, and he is expert in meta-analysis and big data analysis. He is secretary of the Heart Failure Association. Among others, he is Deputy Editor of EHJ-Open, EHJ-CR, and Associate Editor of European Journal of Heart Failure.
Place of work
Karolinska Institute, Stockholm, Sweden
Ivan Stankovic
MD, PhD, Cardiologist - Head of Echocardiography, CHC Zemun, Belgrade, Serbia - President, Echocardiographic Society of Serbia 2018-2020
Place of work
Clinical Hospital Center Zemun, Belgrade (Serbia)
John Cleland
Professor Cleland is a Cardiologist and Director of the Robertson Centre for Biostatistics (Glasgow), an internationally renowned Clinical Trials Unit offering a complete service both to academia and industry for cardiovascular and metabolic disease. His main interest is heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines. Particular current interests include myocardial substrate, congestion & inflammation, telemonitoring & theranostics. He qualified from the University of Glasgow in 1977, completed training at St. Mary's & Hammersmith Hospitals (London) and was awarded a Senior Fellowship by the British Heart Foundation. He was appointed Prof. at the University of Hull and, in 2013, the National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College London. He founded the European Journal of Heart Failure. He is Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure
Place of work
University of Glasgow, Glasgow, United Kingdom of Great Britain & Northern Ireland
Javed Butler
Javed Butler, MD, MPH, MBA, is the President of the Baylor Scott and White Research Institute and Senior Vice President for Baylor Scott and White Health in Dallas, Texas. He holds the Maxwell A. and Gayle H. Clampitt Endowed Chair for research and is a Distinguished Professor of Medicine at the University of Mississippi.
Previously, he was Patrick H. Lehan Chair in Cardiovascular Research and Chairman of the Department of Medicine at the University of Mississippi. He also held leadership roles at Stony Brook University, Emory University, and Vanderbilt University.
Dr. Butler earned his medical degree from Aga Khan University, completing residencies and fellowships at Yale, Vanderbilt, and Harvard. He also holds an MPH from Harvard and an MBA from Emory.
Board-certified in cardiovascular medicine and heart failure, his research focuses on heart failure clinical trials. He serves on committees for the ACC, AHA, NIH, and HFSA and has received prestigious awards, including the Simon Dack Award.
Dr. Butler has authored over 1,300 peer-reviewed publications and serves on editorial boards of multiple cardiovascular journals. He has been recognized in America’s Best Doctors list multiple times.
Place of work
Baylor Scott& White Health, Dallas (United States of America)
Justin Ezekowitz
Ezekowitz is internationally recognized for his contributions to delivering better care for heart-failure patients using creative real-world solutions. Heart failure is a common chronic disease resulting in frequent emergency-department visits, hospitalizations and a reduced quality of life. He has developed a research program that bridges biomedical, clinical and population health. He primarily conducts clinical trials with end-stage heart failure patients. His research focuses on both existing and new therapies, including medications and non-pharmacological approaches for heart patients such as systems of care, salt intake, and getting the right amount of oxygen.
Ezekowitz takes a "save lives with simple solutions" approach to his work as a cardiologist at the U of A’s Heart Function Clinic, which cares for hundreds of patients with advanced heart failure. He says the uniqueness of each patient makes every day a challenge.
Place of work
University of Alberta, Edmonton (Canada)
Kevin Damman
Associate Prof Kevin Damman, MD, PhD, FHFA, studied medicine at the University of Groningen, The Netherlands and received his PhD in 2009 entitled “Cardiorenal Interaction in Heart Failure”. Dr Damman is a clinical cardiologist, Medical Director of the heart transplant and ventricular assist device program at the UMCG, Groningen, The Netherlands. His interests include advanced and acute heart failure. Current research interests are focused on improving treatment of acute heart failure patients, including SGLT2-inhibition in (acute) heart failure and the role of the kidney in the process of cardiorenal interaction. He was co-PI of the PUSH-AHF study on natriuresis guided treatment in acute heart failure and was part of the steering committee of the ADVOR trial investigating acetazolamide in acute heart failure. Dr Damman is associate editor of the European Journal of Heart Failure and is Chair of the working group on Advanced Heart Failure from the HFA
Place of work
University Medical Centre Groningen, Groningen (Netherlands (The))
Lars Lund
Lars Lund is Professor of Cardiology at Karolinska Institutet and Karolinska University Hospital in Stockholm. His research focuses on heart failure: implementation of existing therapy in HFrEF and development of novel therapy in HFpEF.
Place of work
Karolinska University Hospital, Stockholm (Sweden)
Linda Van Laake
Linda W. Van Laake, MD, PhD obtained her medical degree at Maastricht University and her PhD (title: Cardiac Recovery by Stem and Progenitor Cells) at Utrecht University, after which she continued her scientific career as a postdoctoral researcher at the Gladstone Institutes, University of California, San Francisco (USA). In 2011 she became Assistant Professor at the Department of Cardiology of the University Medical Center Utrecht and the Hubrecht Institute Utrecht, the Netherlands. In addition, she works as a clinical cardiologist specialized in heart failure.
Dr. Van Laake is active within the European Society of Cardiology (Nucleus Member of the Working Group on Cellular Biology of the Heart) and European Heart Failure Association (Member of the Translational Committee), and was a founding member of the Jonge Gezondheidsraad, an advisory body to the government and Parliament on the current level of knowledge with respect to public health issues and research.
Place of work
University Medical Center Utercht, Utercht (Netherlands (The))
Maria Generosa Crespo-Leiro
Head, Heart Failure Section, Cardiology Service at the Complexo Hospitalario Universitario A Coruña (CHUAC), Spain. Professor of Medicine, University of A Coruña (UDC) She obtained MD at the University of Santiago de Compostela, Specialization in Cardiology at Clinica Puerta de Hierro (Madrid) and PhD from Universidad Autónoma (Madrid). She served in several scientific societies: President of the Spanish WG on HF and HT (2003-2006); Board of Directors, International Society for Heart and Lung Transplantation (ISHLT) (2010-1013). Board member, Heart Failure Association (HFA) of the ESC (2012-2018). Secretary, HFA Executive Committee (2016-2018). Chair, HFA Advanced HF Committee (2017-2018). Member, ESC Education Committee (2018-2020 and 2024-2026). Main fields of research interest: HF and HT. Chair, ESC HF Long-term Registry (2013-2016), HFA scientific statement on advanced HF (2018), Spanish post-HT Tumor Registry. Co-author 2021 and 2023 ESC HF Guidelines.
Place of work
Cardiology Service at the Complexo Hospitalario Universitario A Coruña (CHUAC), Spain
Marianna Adamo
Marianna Adamo practices in Brescia, Italy. Her top areas of expertise are Mitral Valve Regurgitation, Heart Failure, Tricuspid Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.
Her clinical research consists of co-authoring 290 peer reviewed articles and participating in 1 clinical trial in the past 15 years
Place of work
Cardiology Service at the Complexo Hospitalario Universitario A Coruña (CHUAC), Spain
Maja Cikes
Maja Cikes, MD, PhD, is an associate professor at the University of Zagreb School of Medicine and a cardiologist at the University hospital Centre Zagreb. She received subspecialty and academic training at St. George’s Hospital London, KU Leuven and Univeristatspital Zurich and is an internationally recognized expert in heart failure and cardiac imaging. Her clinical and academic interests span from chronic to advanced heart failure and machine learning. Maja has been involved in many clinical trials and research projects in heart failure, as is currently the principal investigator of several multicentre trials and registries. For the scientific work, she has been awarded the UNESCO L’Oreal award “For Women in Science”, the Basic Science young investigator Award at EuroEcho-Imaging as well as the Croatian Award for Science for 2019.
Place of work
University Hospital Centre Zagreb, Zagreb (Croatia)
Mark Petrie
Heart failure, heart failure devices, heart failure interventions, clinical trials and life enthusiast.
Professor Petrie's has a high-volume clinical practice within a large heart failure team. Mark worked as an interventional and heart failure/transplant cardiologist for many years before transitioning to an academic post. His research interests focus on diabetes and cardiovascular disease, intervention in heart failure, AF ablation in heart failure, subcutaneous furosemide in heart failure, devices in heart failure, revascularization in heart failure, peripartum cardiomyopathy, inflammation in heart failure, microvascular disease in heart failure with preserved ejection fraction, obesity and heart failure, cardiac remodeling, iron in heart failure and cardio-oncology.
Mark is a Board member of the Heart Failure Association of the European Society of Cardiology and chairs its HFpEF/ HFmrEF group. He is a Board member of the British Society of Heart Failure. He co-chairs the Scottish Cardiac Audit Programme and chairs the Clinical Board of the Pumping Marvellous Foundation. Mark is the Deputy Editor of the European Journal of Heart Failure.
Place of work
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northen Irland)
Peter Van Der Meer
Peter van der Meer is a cardiologist, chair of the Department of Experimental Cardiology and professor of Heart Failure and Translational Cardiology at the University of Groningen. Professor van der Meer received both his MD and PhD cum laude and completed a postdoctoral fellowship at Harvard Medical School, Boston, MA, USA. He authored >300 manuscripts, has an H-index of >100 and was member of the 2022 ESC CardioOncology guidelines and is member of the ESC/HFA working group on PeriPartum CardioMyopathy. He is a member of several steering committees of large phase 3 trials. His research is funded by national and international grants including an ERC CoG grant. His research group consists of PhD students and post-docs with various backgrounds (biologists, medical doctors and biomedical-engineers) working on translational research topics. His research focusses on understanding the susceptibility to develop heart failure and on exploring novel treatment targets and therapies.
Place of work
University Medical Centre Groningen, Groningen (Netherlands (The))
Pardeep Jhund
Pardeep Jhund is Professor of Cardiology and Epidemiology at the University of Glasgow and an honorary consultant cardiologist at the Queen Elizabeth University Hospital, Glasgow, UK. His research interests focus on heart failure. He uses clinical trials and epidemiological datasets to understand the epidemiology of cardiovascular disease and test new therapies. Prof Jhund is a Fellow of the European Society of Cardiology (FESC), the Heart Failure Association of the ESC (FHFA) and the Royal College of Physicians Edinburgh. He has co-authored over 400 publications and is the author of chapters in the ESC Textbook of Cardiovascular Medicine and Oxford Textbook of Heart Failure. He is a Highly Cited Researcher as one of the top 1% of researchers in clinical medicine.
Place of work
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
Petar Seferovic
President, Heart failure Association of the ESC • Academician, Serbian Academy of Sciences and Arts • Professor of Internal Medicine, University of Belgrade School of Medicine • Professor, Heart Failure Center, Belgrade University Medical Center • President, Heart Failure Society of Serbia Coauthored 606 publications, with cumulative impact factor of 1078 (h-index 36), including multiple papers in peer-reviewed international journals. He has a total citation of 17833 (Google Scholar) / 14298 (Scopus). He presented more than 260 lectures at international conferences.
Place of work
University Clinical Center of Serbia, Belgrade (Serbia)
Sophie Van Linthout
Prof. Van Linthout has completed her studies in biological engineering at the Catholic University of Leuven, Leuven, Belgium (1998) and finished her PhD in medical science, at the Catholic University of Leuven, Leuven, Belgium (2002). Here after, she was a Marie-Curie Fellow of the European Commission in Italy for 1.5 years. From 2004 on, she worked as a Post-Doc at the Department of Cardiology & Pneumology, Charité, Campus Benjamin Franklin, Berlin, Germany, where her research was mainly directed at finding strategies to improve diabetic cardiopathy and diabetes mellitus-associated endothelial dysfunction. Since 2010 she works at the Berlin-Brandenburg (now, Berlin Institute of Health) Center for Regenerative Therapies at the Charité, University of Medicine, Berlin; Germany, where she leads the working group on translational immunocardiology. Her research is focused on exploring the role of the innate immunity, inflammation and its bidirectional relationship with fibroblasts, in the pathogenesis of non-ischemic heart failure with the main emphasis on inflammatory cardiomyopathy and heart failure with preserved ejection fraction. Prof. Van Linthout is HFA Board member for the basic science section and the chair of the HFA Scientific Committee on Basic & Translational Research.
Languages
Flemish (Dutch), French, English, Italian, German
Place of work
Berlin Institute of Health Center for Regenerative Therapies – Charité, Berlin, Germany
Teresa Lopez Fernandez
Victoria Delgado is a board certified cardiologist with specific expertise in multimodality imaging, Assistant professor of Cardiology at the Leiden University Medical Center. For the past 13 years, I have been actively performing research in the field of cardiac mechanics and underlying pathophysiological mechanisms of heart failure in various cardiac diseases (particularly in valvular heart disease and coronary artery disease). I have been board member of the European Association of Cardiovascular Imaging (councilor and chair of scientific documents), task force member of the European Society of Cardiology (ESC) Guidelines, member of the ESC Guidelines committee and Congress Programme Committee and currently ESC board member. Furthermore, I am associate editor of Circulation and Journal of American Society of Echocardiography.
Place of work
Germans Trials i Pujol Hospital, Barcelona (Spain)
Wilfried Mullens
Prof Wilfried Mullens is a heart failure clinician with a strong commitment to translational research translating new mechanistic insights into answering questions of clinical interest. He has been president of the Belgian Working Group on Heart Failure and servrf as board member of European Heart Failure Association (HFA) and HF 2023 Congress Chair. Prof. Mullens is currently the president-elect of the HFA for the mandate 2024-2026.
Place of work
Hospital Oost-Limburg (ZOL) - Genk, Belgium
Our mission: To reduce the burden of cardiovascular disease.